Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 2,750 shares at $42.51 ($117K) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market sale of $117k VIR by EVP, Research & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.51 | 1,375 | $58K | 50.0% |
| 2 | $42.51 | 1,375 | $58K | 50.0% |
| Total | $42.51 avg | 2,750 | $117K | 100% |
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |